Cooperative regulation of CYP3A5 gene transcription by NF-Y and Sp family members

被引:20
作者
Iwano, S [1 ]
Saito, T [1 ]
Takahashi, Y [1 ]
Fujita, K [1 ]
Kamataki, T [1 ]
机构
[1] Hokkaido Univ, Grad Sch Pharmaceut Sci, Lab Drug Metab, Kita Ku, Sapporo, Hokkaido 0600812, Japan
关键词
cis-acting element; CCAAT box; BTE; transcriptional initiation site; luciferase assay; gel shift assay; cap site hunting method;
D O I
10.1006/bbrc.2001.5352
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The purpose of this study was to clarify the mechanism(s) responsible for the transcriptional regulation of the human CYP3A5 gene. It was found that a region from nucleotides -90 to -40 was involved in the transcriptional activity of the CYP3A5 gene by transfection of a series of 5 ' -truncated promoter-luciferase chimeric genes into human hepatoma HepG2 cells. A gel shift assay using nuclear extracts prepared from HepG2 cells showed that nuclear factor-Y (NF-Y) and specificity protein (Sp) 1 and Sp3 bound to CCAAT box (-78/-68) and a basic transcription element (BTE) (-67/-46) in the CYP3A5 gene. Furthermore, introduction of mutations in the CCAAT box, the BTE, or both elements decreased the transcriptional activity to 10, 21, or 4% of that seen with the intact gene. Thus, we conclude that the transcription of the CYP3A5 gene is cooperatively regulated by NF-Y, Sp1, and Sp3 in HepG2 cells. (C) 2001 Academic Press.
引用
收藏
页码:55 / 60
页数:6
相关论文
共 25 条
[1]  
[Anonymous], MOL CLONING
[2]  
AOYAMA T, 1989, J BIOL CHEM, V264, P10388
[3]   ISOLATION AND SEQUENCE DETERMINATION OF A CDNA CLONE RELATED TO HUMAN CYTOCHROME-P-450 NIFEDIPINE OXIDASE [J].
BEAUNE, PH ;
UMBENHAUER, DR ;
BORK, RW ;
LLOYD, RS ;
GUENGERICH, FP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (21) :8064-8068
[4]  
CHLERTON S, 1992, TRENDS PHARMACOL SCI, V13, P434
[5]   CHARACTERIZATION OF THE CDNA-ENCODING A PROTEIN-BINDING TO THE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II Y-BOX [J].
DIDIER, DK ;
SCHIFFENBAUER, J ;
WOULFE, SL ;
ZACHEIS, M ;
SCHWARTZ, BD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (19) :7322-7326
[6]   ACCURATE TRANSCRIPTION INITIATION BY RNA POLYMERASE-II IN A SOLUBLE EXTRACT FROM ISOLATED MAMMALIAN NUCLEI [J].
DIGNAM, JD ;
LEBOVITZ, RM ;
ROEDER, RG .
NUCLEIC ACIDS RESEARCH, 1983, 11 (05) :1475-1489
[7]   cDNA cloning and initial characterization of CYP3A43, a novel human cytochrome p450 [J].
Domanski, TL ;
Finta, C ;
Halpert, JR ;
Zaphiropoulos, PG .
MOLECULAR PHARMACOLOGY, 2001, 59 (02) :386-392
[8]   Genomic organization of the human CYP3A locus:: identification of a new, inducible CYP3A gene [J].
Gellner, K ;
Eiselt, R ;
Hustert, E ;
Arnold, H ;
Koch, I ;
Haberl, M ;
Deglmann, CJ ;
Burk, O ;
Buntefuss, D ;
Escher, S ;
Bishop, C ;
Koebe, HG ;
Brinkmann, U ;
Klenk, HP ;
Kleine, K ;
Meyer, UA ;
Wojnowski, L .
PHARMACOGENETICS, 2001, 11 (02) :111-121
[9]   A GENERAL-METHOD OF INVITRO PREPARATION AND SPECIFIC MUTAGENESIS OF DNA FRAGMENTS - STUDY OF PROTEIN AND DNA INTERACTIONS [J].
HIGUCHI, R ;
KRUMMEL, B ;
SAIKI, RK .
NUCLEIC ACIDS RESEARCH, 1988, 16 (15) :7351-7367
[10]   Selective expression of CYP3A5 and not CYP3A4 in human blood [J].
Janardan, SK ;
Lown, KS ;
SchmiedlinRen, P ;
Thummel, KE ;
Watkins, PB .
PHARMACOGENETICS, 1996, 6 (05) :379-385